Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 251Neoplasms, Plasma Cell 91Lymphoma, Non-Hodgkin 33Hodgkin Disease 33Leukemia, Lymphocytic, Chronic, B-Cell 30Lymphoma 29Leukemia 29Immunoglobulin Light-chain Amyloidosis 29Myelodysplastic Syndromes 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Leukemia, Myeloid, Acute 25Lymphoma, Mantle-Cell 20Lymphoma, Follicular 20Myeloproliferative Disorders 19Lymphoma, Large B-Cell, Diffuse 19Lymphoma, B-Cell, Marginal Zone 19Recurrence 17Lymphoma, Large-Cell, Immunoblastic 17Burkitt Lymphoma 17Primary Myelofibrosis 14Congenital Abnormalities 14Anemia, Aplastic 13Waldenstrom Macroglobulinemia 12Leukemia, Myeloid, Chronic-Phase 12Leukemia, Myeloid, Accelerated Phase 12Leukemia, Myelomonocytic, Chronic 11Hematologic Neoplasms 11Graft vs Host Disease 11Dendritic Cell Sarcoma, Interdigitating 10Lymphoma, T-Cell, Cutaneous 9

Interventions

Thalidomide 1Melphalan 1Etoposide 1Doxorubicin 1Dexamethasone 1Cyclophosphamide 1Cisplatin 1Calcium Dobesilate 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Polyneuropathies × Melphalan × Plasma cell × Clear all
NCT01548573 2017-06-14

Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment

University of Iowa

Phase 2 Terminated
19 enrolled 7 charts
Plasma cell

Amyloidosis, Endocrine System Diseases, Multiple Myeloma, Paraproteinemias, Polyneuropathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡